Israeli wound management co RedDress raises $26m
RedDress has pioneered a proprietary blood-based technology to treat chronic wounds that has almost zero risk of rejection and is far more cost effective.
Source: globes.co.il
Stay updated with breaking news from Ragnar Crossover. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
RedDress has pioneered a proprietary blood-based technology to treat chronic wounds that has almost zero risk of rejection and is far more cost effective.
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
RedDress, a personalized and autologous wound management solution created from patients own blood, today announced that it has raised…